助眠產品市場－全球產業規模、佔有率、趨勢、機會及預測，依產品類型、睡眠障礙、配銷通路、地區及競爭格局分類，2020-2030年預測

2024年全球助眠產品市場規模為665.2億美元，預計2030年將以6.45%的複合年成長率成長至967.9億美元。助眠產品涵蓋範圍廣泛，包括旨在改善睡眠品質和治療各種睡眠障礙的藥物和非藥物產品及療法，例如藥物、補充劑和專用設備。市場擴張的主要驅動力是全球睡眠障礙盛行率的不斷上升以及人們對睡眠健康的日益重視。全球人口老化、壓力水平的增加以及生活方式的改變都是導致這些睡眠障礙的重要因素。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球助眠產品市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型（床墊和枕頭、藥品、睡眠呼吸中止症設備、其他）
  • 依睡眠障礙類型（失眠、嗜睡症、不寧腿症候群、睡眠呼吸中止症等）
  • 按配銷通路（醫院藥房、零售藥房、電子商務、藥局、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美助眠產品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲助眠產品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區助眠產品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲助眠產品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲助眠產品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球助眠產品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• AstraZeneca Plc
• BMC Medical Co., Ltd.
• Cadwell Industries, Inc
• Compumedics Limited
• Drive DeVilbiss Healthcare Inc
• Eisai Co. Ltd.
• Fisher & Paykel Healthcare Limited
• GlaxoSmithKline Plc
• Idorsia Pharmaceuticals Ltd
• Koninklijke Philips NV

第16章：策略建議

第17章調查會社について,免責事項

The Global Sleeping Aids Market, valued at USD 66.52 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 96.79 Billion by 2030. Sleeping aids encompass a broad spectrum of pharmaceutical and non-pharmaceutical products and therapies designed to enhance sleep quality and address various sleep disorders, including medications, supplements, and specialized devices. The market's expansion is primarily driven by the escalating global prevalence of sleep disorders and a growing awareness of sleep health. An aging global population, increasing stress levels, and changing lifestyles contribute significantly to these disorders.

Key Market Drivers

The increased prevalence of sleep disorders significantly drives the global sleeping aids market. As populations contend with conditions such as insomnia and sleep apnea, demand for effective diagnostic tools and therapeutic interventions grows. For instance, according to a survey commissioned by the American Academy of Sleep Medicine, in June 2024, 12% of Americans reported a diagnosis of chronic insomnia, highlighting a substantial segment of the population seeking relief.

Key Market Challenges

A significant challenge impeding market expansion in the Global Sleeping Aids Market is the ongoing concern regarding the potential side effects and dependency risks associated with certain prescription sleep medications. This apprehension directly influences consumer behavior, often leading individuals to prefer non-pharmacological alternatives or to discontinue treatment. This reluctance to use or continue prescription sleep aids directly hampers market growth in specific product segments. For instance, according to the American Academy of Sleep Medicine's 2024 Sleep in America poll, 38% of adults who experience sleep difficulties reported actively avoiding prescription sleep medication due to worries about potential side effects or addiction. This consumer shift limits sustained market expansion for pharmaceutical solutions, as a substantial portion of the target demographic opts for perceived safer options. The market consequently experiences constrained growth in segments reliant on prescription sales, impacting overall adoption rates and the potential for greater market penetration.

Key Market Trends

The increasing consumer preference for natural and herbal sleep aids is significantly reshaping the global sleeping aids market. Consumers are increasingly seeking alternatives to traditional pharmaceutical options, driven by concerns about potential side effects and dependency risks associated with prescription medications. This shift is expanding the market beyond conventional offerings toward botanical and supplement-based solutions. According to the Council for Responsible Nutrition 2024 Consumer Survey, published in October 2024, magnesium usage among supplement users rose from 19% in 2023 to 23% in 2024, while ashwagandha use increased from 2% in 2020 to 8% in 2024, reflecting growing interest in ingredients often found in natural sleep aids. This rising demand encourages innovation and product development in the natural segment. For instance, in May 2024, Natrol, a prominent melatonin brand, introduced Time Release Melatonin gummies, designed for dual-action delivery to assist with both falling and staying asleep, catering to this evolving consumer preference.

Key Market Players

• AstraZeneca Plc
• BMC Medical Co., Ltd.
• Cadwell Industries, Inc
• Compumedics Limited
• Drive DeVilbiss Healthcare Inc
• Eisai Co. Ltd.
• Fisher & Paykel Healthcare Limited
• GlaxoSmithKline Plc
• Idorsia Pharmaceuticals Ltd
• Koninklijke Philips N.V

Report Scope:

In this report, the Global Sleeping Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sleeping Aids Market, By Product Type:

• Mattresses & Pillows
• Medications
• Sleep Apnea Devices
• Others

Sleeping Aids Market, By Sleep Disorder:

• Insomnia
• Narcolepsy
• Restless Leg Syndrome
• Sleep Apnea
• Others

Sleeping Aids Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• E-commerce
• Drug Stores
• Others

Sleeping Aids Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Sleeping Aids Market.

Available Customizations:

Global Sleeping Aids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sleeping Aids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Mattresses & Pillows, Medications, Sleep Apnea Devices, Others)
  • 5.2.2. By Sleep Disorder (Insomnia, Narcolepsy, Restless Leg Syndrome, Sleep Apnea, Others)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, Drug Stores, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Sleeping Aids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Sleep Disorder
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Sleeping Aids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Sleep Disorder
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Sleeping Aids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Sleep Disorder
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Sleeping Aids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Sleep Disorder
      • 6.3.3.2.3. By Distribution Channel

7. Europe Sleeping Aids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Sleep Disorder
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Sleeping Aids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Sleep Disorder
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Sleeping Aids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Sleep Disorder
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Sleeping Aids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Sleep Disorder
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Sleeping Aids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Sleep Disorder
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Sleeping Aids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Sleep Disorder
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Sleeping Aids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Sleep Disorder
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Sleeping Aids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Sleep Disorder
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Sleeping Aids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Sleep Disorder
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Sleeping Aids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Sleep Disorder
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Sleeping Aids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Sleep Disorder
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Sleeping Aids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Sleep Disorder
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Sleeping Aids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Sleep Disorder
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Sleeping Aids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Sleep Disorder
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Sleeping Aids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Sleep Disorder
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Sleeping Aids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Sleep Disorder
      • 9.3.3.2.3. By Distribution Channel

10. South America Sleeping Aids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Sleep Disorder
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Sleeping Aids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Sleep Disorder
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Sleeping Aids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Sleep Disorder
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Sleeping Aids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Sleep Disorder
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Sleeping Aids Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. AstraZeneca Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BMC Medical Co., Ltd.
• 15.3. Cadwell Industries, Inc
• 15.4. Compumedics Limited
• 15.5. Drive DeVilbiss Healthcare Inc
• 15.6. Eisai Co. Ltd.
• 15.7. Fisher & Paykel Healthcare Limited
• 15.8. GlaxoSmithKline Plc
• 15.9. Idorsia Pharmaceuticals Ltd
• 15.10. Koninklijke Philips N.V

16. Strategic Recommendations

17. About Us & Disclaimer